Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells
In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated...
Saved in:
Published in | Journal of experimental & clinical cancer research Vol. 38; no. 1; pp. 389 - 14 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
05.09.2019
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1756-9966 0392-9078 1756-9966 |
DOI | 10.1186/s13046-019-1384-8 |
Cover
Loading…
Abstract | In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC).
Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs.
Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs.
Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC. |
---|---|
AbstractList | In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC).
Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs.
Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs.
Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC. In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC). Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs. Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs. Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC. Background In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC). Methods Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs. Results Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs. Conclusions Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC. Background In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC). Methods Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs. Results Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs. Conclusions Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC. Keywords: ESCC, Angiogensis, Exosomes, Metastasis Abstract Background In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC). Methods Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs. Results Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs. Conclusions Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC. In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC).BACKGROUNDIn cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the hypoxia and communicate with other mesenchymal cells in microenvironment during tumor development remains to be elucidated. Here, we investigated the involvement of exosomes in modulating angiogenesis and enhancing metastasis in esophageal squamous cell carcinoma (ESCC).Differential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs.METHODSDifferential centrifugation, transmission electron microscopy and nanoparticle tracking analysis were used to isolate and characterize exosomes. Colony formation and transwell assay were performed to assess the proliferation, migration and invasion of human umbilical vein endothelial cells (HUVECs). The tube formation assay and matrigel plug assay were used to evaluate the vascular formation ability of HUVECs in vitro and in vivo respectively. An in vivo nude mice model was established to detect the regulatory role of exosomes in ESCC progression. Microarray analysis was performed to analyze the transcriptome profiles in HUVECs.Exosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs.RESULTSExosomes derived from ESCC cells cultured under hypoxia played a better role in promoting proliferation, migration, invasion and tube formation of HUVECs in vitro and in vivo than exosomes from ESCC cells cultured under normoxia. Moreover, hypoxic exosomes significantly enhanced the tumor growth and lung metastasis compared with normoxic exosomes in nude mice models. Interestingly, endothelial cells were programmed by hypoxic and normoxic exosomes from ESCC cells which altered the transcriptome profile of HUVECs.Taken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC.CONCLUSIONSTaken together, our data identified an angiogenic role of exosomes from ESCC cells which shed light on the further application of exosomes as valuable therapeutic target for ESCC. |
ArticleNumber | 389 |
Audience | Academic |
Author | Cao, Liyan Zhang, Xinyuan Wang, Chao Zhang, Qiang Zhang, Yanqiu Wang, Yimin Mao, Yu Zhang, Yunjie Dong, Lixin Yang, Sen Li, Xin Fu, Zhanzhao |
Author_xml | – sequence: 1 givenname: Yu surname: Mao fullname: Mao, Yu – sequence: 2 givenname: Yimin surname: Wang fullname: Wang, Yimin – sequence: 3 givenname: Lixin surname: Dong fullname: Dong, Lixin – sequence: 4 givenname: Yunjie surname: Zhang fullname: Zhang, Yunjie – sequence: 5 givenname: Yanqiu surname: Zhang fullname: Zhang, Yanqiu – sequence: 6 givenname: Chao surname: Wang fullname: Wang, Chao – sequence: 7 givenname: Qiang surname: Zhang fullname: Zhang, Qiang – sequence: 8 givenname: Sen surname: Yang fullname: Yang, Sen – sequence: 9 givenname: Liyan surname: Cao fullname: Cao, Liyan – sequence: 10 givenname: Xinyuan surname: Zhang fullname: Zhang, Xinyuan – sequence: 11 givenname: Xin surname: Li fullname: Li, Xin – sequence: 12 givenname: Zhanzhao surname: Fu fullname: Fu, Zhanzhao |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31488217$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kl1r1zAUxotM3It-AG8kIIg3nUnavPRGGEPdYOCNXoc0PW0z2qRLUtk-j1_UdP859xeRFpqcPs_vJIfnuDhw3kFRvCb4lBDJP0RS4ZqXmDQlqWRdymfFERGMl03D-cGT9WFxHOM1xpw0pHlRHFaklpIScVT8vLhb_K01CG599DNE1GtjJ5t0AqTdYP0ADqKNedOhGZKO-c1b6xBEv4x6AD2heLPq2a8RGZgmZHQw1vlZozQGvw4j0lOCYN2QC4CWEZxPdwvcM1PQLppgl5TbI98jcJ3Psslm7oaLL4vnvZ4ivHr4nhTfP3_6dn5RXn39cnl-dlUa1pBUcs5rzQSVVWeqhkJfQ2VAmJYaRoBIKXBbs7qjrWEdp0xXRLatpBiw0Kyuq5PicsftvL5WS7CzDnfKa6vuCz4MSodkzQRKdpR0hEJDKdSsw20rsDCUmYYTXFGaWR93rGVtZ-gMuHzPaQ-6_8fZUQ3-h-KCCiZZBrx_AAR_s0JMarZxG4d2kAetKJW8IZSL7dxv_5Je-zW4PKqsamjDmZT8j2rQ-QLW9T73NRtUnXGMaQYKkVWn_1Dlp4PZmhy_3ub6nuHdE8OYw5DG6Kc1We_ivvDN04k8juJ3FrOA7AQm-BgD9I8SgtWWd7XLu8p5V1velcwe8ZfHbNHNvfOx7fQf5y9GGAXK |
CitedBy_id | crossref_primary_10_1007_s10456_021_09819_0 crossref_primary_10_1186_s12964_020_00541_w crossref_primary_10_1186_s12967_020_02662_9 crossref_primary_10_1016_j_critrevonc_2022_103702 crossref_primary_10_1073_pnas_2200252119 crossref_primary_10_4251_wjgo_v16_i4_1578 crossref_primary_10_1111_cas_15801 crossref_primary_10_1016_j_canlet_2022_215796 crossref_primary_10_1186_s13045_022_01305_4 crossref_primary_10_3390_ijms21165840 crossref_primary_10_1002_wnan_1989 crossref_primary_10_3390_cancers13174380 crossref_primary_10_1007_s00018_022_04552_3 crossref_primary_10_1016_j_jbo_2020_100280 crossref_primary_10_1016_j_cytogfr_2023_08_010 crossref_primary_10_1038_s41420_024_01905_8 crossref_primary_10_2147_IJN_S321555 crossref_primary_10_3390_cancers14081969 crossref_primary_10_1016_j_mvr_2021_104297 crossref_primary_10_3390_ijms21145071 crossref_primary_10_3390_cancers14030536 crossref_primary_10_1186_s12929_020_00654_x crossref_primary_10_3748_wjg_v29_i42_5699 crossref_primary_10_3389_fmolb_2021_703640 crossref_primary_10_1080_00365521_2024_2310167 crossref_primary_10_1177_09636897221106998 crossref_primary_10_1016_j_bbcan_2020_188497 crossref_primary_10_2147_CMAR_S258215 crossref_primary_10_3389_fphys_2020_579892 crossref_primary_10_1080_21655979_2022_2060720 crossref_primary_10_3390_biomedicines11092534 crossref_primary_10_1186_s13046_023_02821_y crossref_primary_10_1186_s12967_022_03649_4 crossref_primary_10_2174_1566524022666220321125134 crossref_primary_10_3390_ijms231911789 crossref_primary_10_1021_acsabm_4c00660 crossref_primary_10_1186_s12935_024_03314_4 crossref_primary_10_15252_embj_2021109288 crossref_primary_10_3389_fimmu_2022_824188 crossref_primary_10_1155_2022_5209607 crossref_primary_10_2147_IJN_S479533 crossref_primary_10_3390_jcm9020436 crossref_primary_10_1016_j_phrs_2023_106669 crossref_primary_10_1080_21655979_2021_1974765 crossref_primary_10_1016_j_jconrel_2023_09_034 crossref_primary_10_1016_j_omtn_2023_05_002 crossref_primary_10_1186_s12935_021_02026_3 crossref_primary_10_3390_life12040524 crossref_primary_10_3389_fbioe_2022_772514 crossref_primary_10_3390_cells10123429 crossref_primary_10_3390_ijms241411344 crossref_primary_10_3389_fonc_2021_638357 crossref_primary_10_1007_s13577_024_01068_9 crossref_primary_10_1016_j_lfs_2019_117176 crossref_primary_10_1007_s12094_024_03815_8 crossref_primary_10_1002_cam4_6007 crossref_primary_10_1186_s41983_023_00635_5 crossref_primary_10_1007_s13238_021_00863_6 crossref_primary_10_1016_j_bbcan_2024_189244 crossref_primary_10_1186_s12943_021_01440_5 crossref_primary_10_1016_j_tice_2022_101814 crossref_primary_10_1007_s12672_024_00879_4 crossref_primary_10_1097_CAD_0000000000000961 crossref_primary_10_2174_0115680266304636240626055711 crossref_primary_10_1166_jbt_2022_2896 crossref_primary_10_3389_fcell_2020_611039 crossref_primary_10_1021_acs_jnatprod_2c00457 crossref_primary_10_2147_CMAR_S327621 crossref_primary_10_2144_fsoa_2021_0102 crossref_primary_10_1159_000508302 crossref_primary_10_1186_s12951_022_01609_0 crossref_primary_10_3390_cells10102617 crossref_primary_10_3389_fphar_2023_1172908 crossref_primary_10_4251_wjgo_v13_i5_312 crossref_primary_10_1016_j_gde_2020_12_018 crossref_primary_10_1016_j_lfs_2020_117761 crossref_primary_10_1002_cam4_5002 crossref_primary_10_1021_acs_molpharmaceut_3c00488 crossref_primary_10_1073_pnas_1918086116 crossref_primary_10_1002_1878_0261_12902 crossref_primary_10_1186_s12935_021_01943_7 crossref_primary_10_3389_fonc_2021_732702 crossref_primary_10_1021_acs_bioconjchem_3c00232 crossref_primary_10_1186_s12964_023_01142_z crossref_primary_10_3892_ijo_2023_5530 |
Cites_doi | 10.1016/j.canlet.2015.10.011 10.1177/1010428317698383 10.1038/s41417-018-0032-3 10.1111/cas.14122 10.1016/S0140-6736(12)60643-6 10.3892/ijo.2016.3453 10.1186/s12943-018-0869-y 10.1002/cbf.3276 10.1016/j.canlet.2017.06.027 10.1038/s41467-017-01647-5 10.1007/s12307-013-0142-2 10.1073/pnas.1220998110 10.1186/s12943-019-0995-1 10.12688/f1000research.9118.1 10.1016/j.trecan.2017.05.002 10.1038/nature04871 10.2174/1566524018666181004115304 10.1038/ncb1596 10.1038/s41598-018-27307-2 10.18632/oncotarget.9981 10.1038/ncomms7999 10.3892/or.2014.2986 10.12998/wjcc.v7.i8.908 10.1038/nature05760 10.1038/onc.2017.105 10.1007/s10456-017-9562-9 10.1186/s12943-017-0714-8 10.1111/j.1467-985X.2010.00676_9.x 10.1158/0008-5472.CAN-17-0994 10.1111/joim.12019 10.1002/wics.147 10.1101/gr.1239303 10.1007/978-1-59745-241-0_17 10.1038/ncomms10818 10.1089/dna.2018.4533 10.1111/cas.13336 10.1186/s12943-019-0949-7 10.3322/caac.21387 10.1016/j.tips.2016.04.006 10.1016/j.jconrel.2015.06.029 10.1002/mc.22238 10.1373/clinchem.2015.240028 10.1038/nrc.2017.51 10.1097/PPO.0000000000000138 10.1186/1471-2407-12-421 10.3892/or.2017.5453 10.1146/annurev-cellbio-092910-154002 10.1186/s13046-018-0845-9 10.1002/jcp.27429 10.1007/s10555-010-9224-5 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s). 2019 |
Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s). 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13046-019-1384-8 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1756-9966 |
EndPage | 14 |
ExternalDocumentID | oai_doaj_org_article_8d21d12e922e45d0bb707c25c9610322 PMC6727585 A600222877 31488217 10_1186_s13046_019_1384_8 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Scientific Research Fund of Hebei Health and Family Planning Commission grantid: 20181192 – fundername: ; grantid: 20181192 |
GroupedDBID | --- 0R~ 29K 2WC 4.4 5GY 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFO ACGFS ADBBV ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AOIJS BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 D-I DIK DU5 E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ H13 HMCUK HYE IAO IEA IHR IHW INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP ~8M CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c591t-6664a57283dc392ef4e3ce7cb2c51e18870b454d2bc5d625a318bb820e07a5443 |
IEDL.DBID | M48 |
ISSN | 1756-9966 0392-9078 |
IngestDate | Wed Aug 27 01:30:50 EDT 2025 Thu Aug 21 18:17:58 EDT 2025 Sun Aug 24 03:44:45 EDT 2025 Sat Aug 23 13:36:52 EDT 2025 Tue Jun 17 21:25:19 EDT 2025 Tue Jun 10 20:18:10 EDT 2025 Thu May 22 21:21:21 EDT 2025 Thu Apr 03 07:03:22 EDT 2025 Thu Apr 24 22:55:38 EDT 2025 Tue Jul 01 02:26:37 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Angiogensis Metastasis Exosomes ESCC |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c591t-6664a57283dc392ef4e3ce7cb2c51e18870b454d2bc5d625a318bb820e07a5443 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2292965886?pq-origsite=%requestingapplication% |
PMID | 31488217 |
PQID | 2292965886 |
PQPubID | 105475 |
PageCount | 14 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8d21d12e922e45d0bb707c25c9610322 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6727585 proquest_miscellaneous_2286912674 proquest_journals_2292965886 gale_infotracmisc_A600222877 gale_infotracacademiconefile_A600222877 gale_healthsolutions_A600222877 pubmed_primary_31488217 crossref_primary_10_1186_s13046_019_1384_8 crossref_citationtrail_10_1186_s13046_019_1384_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-09-05 |
PublicationDateYYYYMMDD | 2019-09-05 |
PublicationDate_xml | – month: 09 year: 2019 text: 2019-09-05 day: 05 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | Journal of experimental & clinical cancer research |
PublicationTitleAlternate | J Exp Clin Cancer Res |
PublicationYear | 2019 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | EC Finger (1384_CR32) 2010; 29 RL Siegel (1384_CR1) 2017; 67 L Milane (1384_CR9) 2015; 219 Z Zhong (1384_CR49) 2017; 403 T Shen (1384_CR51) 2017; 37 1384_CR24 HW King (1384_CR35) 2012; 12 J Pasquier (1384_CR40) 2014; 7 Y Mao (1384_CR22) 2016; 7 X Ma (1384_CR44) 2017; 8 J Liao (1384_CR17) 2016; 48 DC Allen (1384_CR2) 2013; 381 P Kucharzewska (1384_CR19) 2013; 110 C Ginestet (1384_CR26) 2011; 174 H Valadi (1384_CR10) 2007; 9 P Shannon (1384_CR29) 2003; 13 C Viallard (1384_CR5) 2017; 20 M Kang (1384_CR12) 2018; 37 S Damian (1384_CR27) 2015; 43 S Rey (1384_CR6) 2017; 3 NJ Taylor (1384_CR47) 2015; 54 H Shao (1384_CR42) 2015; 6 T Muetze (1384_CR28) 2016; 5 MC Lowry (1384_CR11) 2015; 61 Yu Mao (1384_CR18) 2019; 110 H Wickham (1384_CR25) 2015; 3 L Claesson-Welsh (1384_CR48) 2013; 273 J Pouyssegur (1384_CR31) 2006; 441 CF Ruivo (1384_CR14) 2017; 77 Y Mao (1384_CR20) 2018; 8 W Wang (1384_CR52) 2017; 39 AS Chung (1384_CR8) 2011; 27 LL Su (1384_CR15) 2019; 7 Y Du (1384_CR50) 2018; 18 Y Mao (1384_CR21) 2019; 234 M Xue (1384_CR30) 2017; 16 Y Liu (1384_CR33) 2016; 370 KM Malinda (1384_CR23) 2009; 467 Y Guo (1384_CR38) 2019; 18 GP Gupta (1384_CR39) 2007; 446 L Jia (1384_CR45) 2016; 7 YL Cao (1384_CR41) 2017; 35 N Syn (1384_CR34) 2016; 37 M De Palma (1384_CR7) 2017; 17 N Maishi (1384_CR37) 2017; 108 YL Hsu (1384_CR43) 2017; 36 Z Jiang (1384_CR46) 2014; 31 L Mao (1384_CR13) 2018; 25 D Predescu (1384_CR3) 2012; 107 C Shao (1384_CR36) 2018; 17 DR Bielenberg (1384_CR4) 2015; 21 W Li (1384_CR16) 2019; 18 |
References_xml | – volume: 370 start-page: 125 issue: 1 year: 2016 ident: 1384_CR33 publication-title: Cancer Lett doi: 10.1016/j.canlet.2015.10.011 – volume: 39 start-page: 101042831769838 issue: 6 year: 2017 ident: 1384_CR52 publication-title: Tumour Biol doi: 10.1177/1010428317698383 – volume: 25 start-page: 248 issue: 9–10 year: 2018 ident: 1384_CR13 publication-title: Cancer Gene Ther doi: 10.1038/s41417-018-0032-3 – volume: 110 start-page: 2700 issue: 9 year: 2019 ident: 1384_CR18 publication-title: Cancer Science doi: 10.1111/cas.14122 – volume: 381 start-page: 400 issue: 9864 year: 2013 ident: 1384_CR2 publication-title: Lancet. doi: 10.1016/S0140-6736(12)60643-6 – volume: 48 start-page: 2567 issue: 6 year: 2016 ident: 1384_CR17 publication-title: Int J Oncol doi: 10.3892/ijo.2016.3453 – volume: 17 start-page: 120 issue: 1 year: 2018 ident: 1384_CR36 publication-title: Mol Cancer doi: 10.1186/s12943-018-0869-y – volume: 35 start-page: 296 issue: 6 year: 2017 ident: 1384_CR41 publication-title: Cell Biochem Funct doi: 10.1002/cbf.3276 – volume: 403 start-page: 305 year: 2017 ident: 1384_CR49 publication-title: Cancer Lett doi: 10.1016/j.canlet.2017.06.027 – volume: 8 start-page: 1506 issue: 1 year: 2017 ident: 1384_CR44 publication-title: Nat Commun doi: 10.1038/s41467-017-01647-5 – volume: 7 start-page: 41 issue: 1–2 year: 2014 ident: 1384_CR40 publication-title: Cancer Microenvironment doi: 10.1007/s12307-013-0142-2 – volume: 110 start-page: 7312 issue: 18 year: 2013 ident: 1384_CR19 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1220998110 – volume: 18 start-page: 39 issue: 1 year: 2019 ident: 1384_CR38 publication-title: Mol Cancer doi: 10.1186/s12943-019-0995-1 – volume: 5 start-page: 1745 year: 2016 ident: 1384_CR28 publication-title: F1000Research doi: 10.12688/f1000research.9118.1 – volume: 3 start-page: 529 issue: 7 year: 2017 ident: 1384_CR6 publication-title: Trends Cancer doi: 10.1016/j.trecan.2017.05.002 – volume: 441 start-page: 437 issue: 7092 year: 2006 ident: 1384_CR31 publication-title: Nature. doi: 10.1038/nature04871 – volume: 18 start-page: 273 issue: 5 year: 2018 ident: 1384_CR50 publication-title: Curr Mol Med doi: 10.2174/1566524018666181004115304 – volume: 9 start-page: 654 issue: 6 year: 2007 ident: 1384_CR10 publication-title: Nat Cell Biol doi: 10.1038/ncb1596 – volume: 8 start-page: 8823 issue: 1 year: 2018 ident: 1384_CR20 publication-title: Sci Rep doi: 10.1038/s41598-018-27307-2 – volume: 7 start-page: 51223 issue: 32 year: 2016 ident: 1384_CR22 publication-title: Oncotarget. doi: 10.18632/oncotarget.9981 – volume: 6 start-page: 6999 year: 2015 ident: 1384_CR42 publication-title: Nat Commun doi: 10.1038/ncomms7999 – volume: 31 start-page: 1249 issue: 3 year: 2014 ident: 1384_CR46 publication-title: Oncol Rep doi: 10.3892/or.2014.2986 – volume: 7 start-page: 908 issue: 8 year: 2019 ident: 1384_CR15 publication-title: World J Clin Cases doi: 10.12998/wjcc.v7.i8.908 – volume: 43 start-page: D447 issue: Database issue year: 2015 ident: 1384_CR27 publication-title: Nucleic Acids Res – volume: 446 start-page: 765 issue: 7137 year: 2007 ident: 1384_CR39 publication-title: Nature. doi: 10.1038/nature05760 – volume: 36 start-page: 4929 issue: 34 year: 2017 ident: 1384_CR43 publication-title: Oncogene. doi: 10.1038/onc.2017.105 – volume: 20 start-page: 409 issue: 4 year: 2017 ident: 1384_CR5 publication-title: Angiogenesis. doi: 10.1007/s10456-017-9562-9 – volume: 16 start-page: 143 issue: 1 year: 2017 ident: 1384_CR30 publication-title: Mol Cancer doi: 10.1186/s12943-017-0714-8 – volume: 174 start-page: 245 issue: 1 year: 2011 ident: 1384_CR26 publication-title: J R Stat Soc doi: 10.1111/j.1467-985X.2010.00676_9.x – volume: 107 start-page: 583 issue: 5 year: 2012 ident: 1384_CR3 publication-title: Chirurgia (Bucharest, Romania : 1990) – volume: 77 start-page: 6480 issue: 23 year: 2017 ident: 1384_CR14 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-0994 – volume: 273 start-page: 114 issue: 2 year: 2013 ident: 1384_CR48 publication-title: J Intern Med doi: 10.1111/joim.12019 – volume: 3 start-page: 180 issue: 2 year: 2015 ident: 1384_CR25 publication-title: Wiley Interdisciplinary Rev Comp Stat doi: 10.1002/wics.147 – volume: 13 start-page: 2498 issue: 11 year: 2003 ident: 1384_CR29 publication-title: Genome Res doi: 10.1101/gr.1239303 – volume: 467 start-page: 287 year: 2009 ident: 1384_CR23 publication-title: Methods Mole Biol (Clifton, NJ) doi: 10.1007/978-1-59745-241-0_17 – volume: 7 start-page: 10818 year: 2016 ident: 1384_CR45 publication-title: Nat Commun doi: 10.1038/ncomms10818 – ident: 1384_CR24 doi: 10.1089/dna.2018.4533 – volume: 108 start-page: 1921 issue: 10 year: 2017 ident: 1384_CR37 publication-title: Cancer Sci doi: 10.1111/cas.13336 – volume: 18 start-page: 22 issue: 1 year: 2019 ident: 1384_CR16 publication-title: Mol Cancer doi: 10.1186/s12943-019-0949-7 – volume: 67 start-page: 7 issue: 1 year: 2017 ident: 1384_CR1 publication-title: CA Cancer J Clin doi: 10.3322/caac.21387 – volume: 37 start-page: 606 issue: 7 year: 2016 ident: 1384_CR34 publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2016.04.006 – volume: 219 start-page: 278 year: 2015 ident: 1384_CR9 publication-title: J Control Release doi: 10.1016/j.jconrel.2015.06.029 – volume: 54 start-page: 1668 issue: 12 year: 2015 ident: 1384_CR47 publication-title: Mol Carcinog doi: 10.1002/mc.22238 – volume: 61 start-page: 1457 issue: 12 year: 2015 ident: 1384_CR11 publication-title: Clin Chem doi: 10.1373/clinchem.2015.240028 – volume: 17 start-page: 457 issue: 8 year: 2017 ident: 1384_CR7 publication-title: Nat Rev Cancer doi: 10.1038/nrc.2017.51 – volume: 21 start-page: 267 issue: 4 year: 2015 ident: 1384_CR4 publication-title: Cancer J doi: 10.1097/PPO.0000000000000138 – volume: 12 start-page: 421 issue: 1 year: 2012 ident: 1384_CR35 publication-title: BMC Cancer doi: 10.1186/1471-2407-12-421 – volume: 37 start-page: 2095 issue: 4 year: 2017 ident: 1384_CR51 publication-title: Oncol Rep doi: 10.3892/or.2017.5453 – volume: 27 start-page: 563 year: 2011 ident: 1384_CR8 publication-title: Annu Rev Cell Dev Biol doi: 10.1146/annurev-cellbio-092910-154002 – volume: 37 start-page: 171 issue: 1 year: 2018 ident: 1384_CR12 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-018-0845-9 – volume: 234 start-page: 6810 issue: 5 year: 2019 ident: 1384_CR21 publication-title: J Cell Physiol doi: 10.1002/jcp.27429 – volume: 29 start-page: 285 issue: 2 year: 2010 ident: 1384_CR32 publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-010-9224-5 |
SSID | ssj0061919 |
Score | 2.5162363 |
Snippet | In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt to the... Background In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer cells adapt... Abstract Background In cancer progression, hypoxia, or low oxygen tension, is a major regulator of tumor aggressiveness and metastasis. However, how cancer... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 389 |
SubjectTerms | Angiogenesis Angiogensis Animals Cancer cells Cancer metastasis Carcinoma Care and treatment Cell Cycle Cell Line, Tumor Computational Biology - methods Development and progression Disease Models, Animal Disease Progression DNA microarrays Electron microscopy Endothelial Cells Endothelium ESCC Esophageal cancer Esophageal Squamous Cell Carcinoma - genetics Esophageal Squamous Cell Carcinoma - metabolism Esophageal Squamous Cell Carcinoma - pathology Esophagus Exosomes Exosomes - metabolism Gene Expression Profiling Genetic aspects Humans Hypoxia Hypoxia - genetics Hypoxia - metabolism Metastasis Mice Microscopy Molecular Sequence Annotation Neoplasm Metastasis Neoplasm Staging Neovascularization, Pathologic - genetics Neovascularization, Pathologic - metabolism Phenotype Squamous cell carcinoma Stem cells Transcription (Genetics) Transcriptome Tumors |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yD-KL-G311AiCIJRr0nw0j6d4LML55MG9hXz1XLht72wPzr_Hf9SZtLtsEfTFxzaTbDcz-c1MJpkh5J3ytRZtLUofDTgotTal0a0pnTOiDt6pEPC-8-lXtToTX87l-V6pLzwTNqUHnibuqImcRcaT4TwJGSvvdaUDl8EozAWX0Rd03taZmjAYvAJm5hgma9TRwDAACG6zwZx7omwWWign6_8Tkvd00vK85J4COnlA7s-WIz2evvghuZO6R-Tu6Rwbf0x-rX5e9bfrQNNtP_SbNNDWhSkHd6Kuu1j3F4hr6wEeIt2k0YFhiI_rjiYsZgDIAuMP1zcOtwMobunTgKWGun7j6FzQh-bwOug7eJEoHhDrcRc3jzmi3ssoBD9P-5amLuIFr0uQ8Tzc8IScnXz-9mlVziUYyiANG0twboSTGmyQGMCSSq1IdUg6eB4kSwwQqvJCish9kBFcKQcQ4T1YFanSDlPrPSUHXd-l54TKSrVR6yhanwSLDky_GESoJYPelXMFqbYssWHOT45lMi5t9lMaZScuWuCiRS7apiAfdl2upuQcfyP-iHzeEWJe7fwCpM3O0mb_JW0FeYNSYqdLqjt0sMcq3yputC7I-0yB-ACfH9x8zQEmATNtLSgPF5SwrsOyeSuJdsaVwXIO5iwYjY0qyNtdM_bEs3JdAvEAmkYZxpUWBXk2Ce7uT9fg_TbghRZEL0R6MSvLlm79PWcdx5A9-JYv_sc0viT3OC5GDMzJQ3Iw_rhJr8C4G_3rvI5_Ay_wTeU priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgifls9NYIgCOXaNB_tk5zisQjnkwf7FvLVdeG23bvuwfn3-I86k2brFeEe20zSj5nMzC-TzBDyQdpK8bbiufUNAJRKNXmj2iY3puGVs0Y6h-edT3_IxRn_vhTLtOA2pG2Ve50YFbXvHa6RHzEGhhzMZS0_by9yrBqF0dVUQuMuuYepyxB8qeUEuAAbxMIeYCFljn59imqWtTwaSgwJApBuMAsfz-uZXYrp-_9X0jes1HwH5Q2TdPKIPEy-JD0emf-Y3AndE3L_NEXLn5I_i9_b_nrtaLjuh34TBtoaN2blDtR0q3W_Qk23HuDC003YGXAV8XLd0YDlDUDXwPjDxZXBBQKKi_zUYfGhrt8Ymkr80BhwBwsINwLFLWM9ruvGMXdoCaNegsfTvqWh83jk6xykPg43PCNnJ99-fl3kqShD7kRT7nKAO9wIBV6Jd-BbhZaHygXlLHOiDCXorMJywT2zTngAVwaUhrXgZ4RCGUy295wcdH0XXhIqCtl6pTxvbeClN-AMesddJUroXRiTkWLPEu1SxnIsnHGuI3KppR65qIGLGrmo64x8mrpsx3QdtxF_QT5PhJhpO97oL1c6TVxde1b6koWGscCFL6xVhXJMuEZiLkKWkXcoJXo8tjrpC30s4znjWqmMfIwUqDHg9Z1JBx_gJ2DurRnl4YwSZrqbN-8lUSdNM-h_8yIj76dm7Im757oA4gE0tWxKJhXPyItRcKePrgAP14BLM6JmIj37K_OWbv0r5iHHID6gzVe3v9Zr8oDhNMMgnDgkB7vLq_AGHLmdfRtn61-xWkie priority: 102 providerName: ProQuest |
Title | Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31488217 https://www.proquest.com/docview/2292965886 https://www.proquest.com/docview/2286912674 https://pubmed.ncbi.nlm.nih.gov/PMC6727585 https://doaj.org/article/8d21d12e922e45d0bb707c25c9610322 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1ba9swFBa9wNjL2H3eukyDwWDgzZZly34YoxktYZAyygJlL0I3Z4HEbuMU0t-zP7pzZMfUrGwvAVtHSiKd26cjnUPIu0wngpcJD7UtAKAkoggLURahUgVPjFaZMXjfeXqWTWb820V6sUd25a26CWzuhHZYT2q2Xn7cXt18AYH_7AU-zz41MYb3ABQXmFGPh_k-OQTDJLCSw5T3QQWACr7ORwQuQQiYMO-CnHcOMTBTPpv_3zr7ltEaHqi8ZaFOH5IHnWtJj1teeET2XPWY3Jt2wfMn5Pfk5rLeLgx127qpV66hpTJtkm5HVTVf1HNUfIsGHixduY0CzxEfFxV1WO0AVA-M31xdK9wvoLjnTw3WIqrqlaJdxR_q4-9gEOGFo3iCrMZtXj_mBg2jV1Pw9bQuqass3gBbghD44ZqnZHZ68uPrJOxqNIQmLeJNCOiHq1SAk2INzKsruUuME0Yzk8YuBhUWaZ5yy7RJLWAtBTpEa3A7XCQU5t57Rg6qunIvCE2jrLRCWF5qx2OrwDe0hpskjaF3pFRAot2SSNMlMMc6GkvpgUyeyXYVJayixFWUeUA-9F0u2-wd_yIe4zr3hJh427-o13PZybHMLYttzFzBmOOpjbQWkTAsNUWGqQlZQN4gl8j2FmuvPuRx5q8d50IE5L2nQJaGn29Udw8CJgFTcQ0ojwaUIPhm2LzjRLmTG8kY-LvgVeZZQN72zdgTD9NVDtgDaPKsiFkmeECet4zb_-kE4HEOMDUgYsDSg1kZtlSLXz4tOcb0AXy-_O8MvCL3GUoahuXSI3KwWV-71-DabfSI7IsLMSKH45Oz7-cjv0Ey8kIMn-fjn38A6O9RDQ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwELdGJwEviP8EBjMSCAkpWuI4dvKA0AabOrZOCG3S3jzHdkqlNemWTmyfh3c-I3dOWhYh7W2PSc5umjv_7s7nuyPknSgSycuEh4XNwUFJZB7mssxDrXOemEILYzDfeXQghkf823F6vEL-LHJh8FjlAhM9UNva4B75BmOgyEFdZuLz7CzErlEYXV200GjFYs9d_QKXrfm0-xX4-56xne3DL8Ow6yoQmjSP5yHY61ynEtSqNWAcuJK7xDhpCmbS2MWw6KKCp9yywqQWvAMNUl8UoChdJDVWi4N575BVnoCpMCCrW9sH338ssB-8Ed9KBHSyCNGT6OKocSY2mhiDkOC651j3j4dZTxP6hgH_q4VrerF_ZvOaEtx5SB501ivdbMXtEVlx1WNyd9TF55-Q38OrWX05MdRd1k09dQ0ttWnrgDuqq_GkHiO2Thq4sHTq5hqMU7ycVNRhQwVAN5i_ObvQuCVBMaxADbY7quqppl1TIepD_KBz4YajeEitxp1kP-ccda9HQvh5WpfUVRaTzE5hnfnpmqfk6FYY9owMqrpyLwhNI1FaKS0vC8djq8H8tIabJI1hdKR1QKIFS5TpaqRjq45T5X2lTKiWiwq4qJCLKgvIx-WQWVsg5CbiLeTzkhBre_sb9flYdVChMstiGzOXM-Z4aqOikJE0LDW5wOqHLCDrKCWqTZRdIpTaFD6zOZMyIB88BWIUvL7RXaoFfASs9tWjXOtRAraY_uOFJKoO2xr1byUG5O3yMY7E83qVA_EAmkzkMROSB-R5K7jLP52AB56BJxwQ2RPp3lfpP6kmP33lczw2AP7ty5tfa53cGx6O9tX-7sHeK3Kf4ZLDEGC6Rgbz8wv3GszIefGmW7uUnNw2XPwFMUyF2Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hypoxic+exosomes+facilitate+angiogenesis+and+metastasis+in+esophageal+squamous+cell+carcinoma+through+altering+the+phenotype+and+transcriptome+of+endothelial+cells&rft.jtitle=Journal+of+experimental+%26+clinical+cancer+research&rft.au=Wang%2C+Chao&rft.au=Zhang%2C+Xinyuan&rft.au=Dong%2C+Lixin&rft.au=Yang%2C+Sen&rft.date=2019-09-05&rft.pub=BioMed+Central+Ltd&rft.issn=0392-9078&rft.volume=38&rft.issue=1&rft_id=info:doi/10.1186%2Fs13046-019-1384-8&rft.externalDBID=n%2Fa&rft.externalDocID=A600222877 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-9966&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-9966&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-9966&client=summon |